Theories proposed have included a greater potency of the AD risk associated with the APOE ε4 allele and the BDNF Met66 allele in females, differences in sex hormones, smaller head size, lower cognitive reserve, as well as the possibility of differential expression of a variety of genes (reviewed in1,5–23). This evidence concerns the gene APOE and Alzheimer disease.